Moreover, FATS expression is deficient or silent not only in mouse lymphomas and multiple human cancer cell lines [82], but also in clinical tumor samples from patients with ovarian, breast and lung cancer [107–109], demonstrating that FATS is a CFS gene at FRA10F. This evidence concerns the gene C10orf90 and neoplasm.